RxDoctor Payments Data

Charles Warwick

Acute Care · Neptune, NJNPI 1306250071

Payments from drug & device makers

What this record shows

18 manufacturers reported payments, led by Microtransponder, Inc. at 59.5% of the total. 2025 is the largest year on record at $2,634, more than ten times the $49 reported in 2021. Among acute care clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,440in general payments, 2019–2025

Across 46 payments — averaging $74.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microtransponder, Inc.$2K
  • Medtronic$626
  • AstraZeneca$125
  • Insightec,inc$118
  • Boston Scientific$112
  • GT Medical Technologies, Inc$90
  • plus $321 from 12 others
$3,975in research payments, 2019–2025

Across 5 payments — averaging $795.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Hubly Incorporated$4K

What the payments were for

  • Travel & lodging$1,75851%
  • Food & beverage$1,68349%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,440 in reported general payments places this provider in the 90th percentile of 656 acute care providers in New Jersey.

See all acute care providers in New Jersey

Medicare billing

Part B allowed, 2024
$2,435
Medicare patients
16
Services billed
20

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in Neptune

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →